Skip to search formSkip to main contentSkip to account menu

VePesid-Ifosfamide-Platinol Regimen

Known as: VP16-Ifosfamide-Platinol Regimen, Etoposide-Ifosfamide-Cisplatin Regimen, VIP 
A regimen consisting of etoposide, ifosfamide and cisplatin used for the treatment of advanced-stage germ cell gonadal cancers.
National Institutes of Health

Related topics

Related topics

5 relations
CisplatinEtoposideIfosfamideTesticular malignant germ cell tumor

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer…
PURPOSE To evaluate the feasibility and the toxicity of sequential, dose-intensified chemotherapy combined with paclitaxel plus… 
Review
2004
Review
2004
VIP (Etoposide, Ifosfamide, Cisplatin) in Adult Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors
Despite the fact that Ewing sarcoma family of tumors (ET) is chemosensitive, long-term survival is extremely rare for patients… 
Highly Cited
2001
Highly Cited
2001
VIP receptors as molecular targets of breast cancer: implications for targeted imaging and drug delivery.
2000
2000
VIP and PACAP Induce Shift to a Th2 Response by Upregulating B7.2 Expression
Abstract: VIP and PACAP, two structurally related neuropeptides produced within the lymphoid microenvironment, modulate several… 
1999
1999
Peripheral blood progenitor cell (PBPC) mobilization in heavily pretreated patients with germ cell tumors: a report of 34 cases
The aim of the study was to evaluate peripheral blood progenitor cell mobilization by disease-specific chemotherapy in heavily… 
1995
1995
Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: a…
PURPOSE Ifosfamide-containing therapy with cisplatin plus either etoposide (VIP) or vinblastine (VeIP) can cure of patients with… 
1994
1994
A comparative study of cisplatin and vinblastine versus ifosfamide, cisplatin and vinblastine in non-operable non-small-cell lung cancer. A study of the Hellenic Co-operative Oncology Group for Lung…
PURPOSE To evaluate the efficacy and toxicity of ifosfamide in combination with cisplatin and vinblastine in non-operable non… 
1992
1992
Etoposide, Ifosfamide, and Cisplatin in Extensive Small Cell Lung Cancer
From December 1987 through April 1989, 40 patients with extensive‐stage small cell carcinoma of the lung were enrolled in a… 
Review
1992
Review
1992
Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease.
1980
1980
Differential effects of guanine nucleotides on the first step of VIP and glucagon action in membranes from liver cells.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)